Hospira Inc. Announces Lot Recall After Hair Found in IV Solution

Hospira Inc. announced the recall this month of an amino acid IV solution used as a nutritional treatment after a patient found a human hair in the product. According to a Law360 report, the hair could have caused inflammation or an allergic response to the patient. Hospira issued a voluntary recall following the discovery for one of its Aminosyn II …

Woman Files Zoloft Lawsuit After Daughter Born With Craniosynostosis

A woman has filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania alleging that the antidepressant Zoloft caused her daughter to be born with a birth defect. According to the lawsuit, the woman’s daughter was born with craniosynostosis, a skull condition that challenges a child’s bone growth and can lead to stunted brain development. According …

Elite Army Units To Stop Taking Mefloquine After FDA Warning of Permanent Brain Damage

As reported on the FDA website (7/29/13), Psychiatric News (9/9/13 Levin) and today on ABC news (9/9/13 Jelinick), the FDA is advising the public about strengthened and updated warnings regarding the serious neurologic and psychiatric side effects associated with the antimalarial drug, mefloquine hydrochloride taken by many soldiers.   As a result, ABC News reports today that “the top doctor for Green Berets and other elite Army …

Michigan AG Seeks To Tighten Oversight of Compounding Pharmacies

The Detroit Free Press (9/19, Zaniewski) reports that “Michigan Attorney General Bill Schuette plans to announce legislation…aimed at tightening regulations of compounding pharmacies in the state hit hardest by a national fungal meningitis outbreak.” Last September, the fungal meningitis outbreak sickened hundreds of people and killed more than 60.  It was linked to contaminated steroids prepared by the New England Compounding Center, …

More Than 70,000 Women Have Filed Mirena IUD Complaints With FDA

According to WEWS-TV in Cleveland, more than 70,000 women have filed complaints with the US Food and Drug Administration (FDA) over the Mirena intrauterine device (IUD). More than 2 million people currently use the birth control device in the U.S., which also limits heavy menstrual flow. However, WEWS reported that since 2008, 4,775 women have reported that the device dislocated …

Bard Settles Second Vaginal Mesh Case

Bloomberg News (9/14, Feeley) reports that C.R. Bard, Inc. has “agreed to settle a woman’s claims that one of its vaginal-mesh implants caused internal problems before a trial set for this month in New Jersey.”   Specifically, Bard  agreed to pay an undisclosed sum for serious urinary problems caused by Bard’s Avaulta Plus insert.  This is the second vaginal-mesh case Bard settled since …

Philadelphia Woman Files Lawsuit Over Alleged Lipitor Diabetes

A Philadelphia woman is suing the manufacturers of the cholesterol drug Lipitor after she allegedly developed diabetes as a result of taking the drug. According to the Pennsylvania Record, Doris Brown alleges that she developed Type 2 diabetes after she began cholesterol treatment with the drug Lipitor in 2009. Brown said that she was prescribed the drug to reduce her …

J&J Recent Recalls Raising Quality Control Improvement Concerns

The New York Times (9/13, Thomas) reports that the recalls of a lot of Risperdal Consta, (an injectable antipsychotic treatment) and 200,000 bottles of liquid Motrin for infants, have raised new questions about whether Johnson & Johnson “has moved on from its past problems” with quality lapses. Last week, J & J recalled 200,000 bottles of liquid Motrin for infants because they may …

Woman Files Yaz Lawsuit After Suffering Pulmonary Embolism

A woman has filed a lawsuit in the U.S. District Court of Wyoming, alleging that she suffered a pulmonary embolism because she took the birth control drug Yaz. Yaz, or Yasmin and Ocella contain combinations of estrogen and progesterone. According to the woman’s lawsuit, she was not notified of the dangers associated with the drug, which her doctor allegedly said …

FDA Limits Use of Nizoral Antifungal Tablets Due to Risks for Liver Injury

The Food and Drug Administration (FDA) has issued a safety notice saying that the fungal pill Nizoral (ketoconazole) can cause severe liver injuries and adrenal gland problems and shouldn’t be used as a first-line treatment. The FDA is taking several actions related to Nizoral  oral tablets, including limiting the drug’s use, warning that it can cause severe liver injuries and adrenal …